T50.2
Poisoning by, adverse effect of and underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
Clinical Classification Guidelines
Inclusion Terms
- Poisoning by, adverse effect of and underdosing of acetazolamide
Medical Intelligence & Overview
ICD-10 code T50.2 pertains to poisoning, adverse effects, or underuse of specific diuretics, including carbonic anhydrase inhibitors like acetazolamide, benzothiadiazides, and other diuretics. These medications are commonly prescribed to manage conditions such as glaucoma, edema, and hypertension. While effective when used correctly, improper use or overdose can lead to serious health issues. Recognizing the potential risks associated with these drugs helps in ensuring safe treatment and prompt management of adverse reactions.
Causes & Symptoms
Clinical Causes: Overdose or accidental ingestion of diuretics Incorrect dosage or prolonged use without medical supervision Drug interactions that enhance diuretic effects Individual sensitivities or allergic reactions to diuretics Misadministration or misunderstanding of prescribed doses
Key Symptoms: Electrolyte imbalances leading to symptoms such as muscle weakness, cramps, or irregular heartbeat Dehydration signs including dry mouth, dizziness, or decreased urine output Metabolic disturbances like metabolic acidosis or alkalosis Hypotension or low blood pressure, resulting in dizziness or fainting Gastrointestinal issues such as nausea or vomiting Signs of allergic reactions like rash, itching, or swelling Worsening of underlying conditions due to improper medication use
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves reviewing medical history, medication usage, and clinical symptoms. Blood tests are essential to identify electrolyte imbalances, kidney function, and metabolic disturbances. Urinalysis may also be performed to assess the impact on renal function and electrolyte levels. Healthcare providers may evaluate medication adherence and potential drug interactions during the diagnostic process.
Treatment Protocols: Management of poisoning or adverse effects involves stopping or adjusting the medication under medical supervision. Supportive care includes correcting electrolyte imbalances with IV fluids or medications, monitoring vital signs, and managing symptoms. In severe cases, hospitalization may be necessary for intensive treatment. Preventive strategies include proper medication adherence, regular monitoring, and communication between patients and healthcare professionals regarding any side effects experienced.
Clinical Advice & FAQs
Billing Guidance
Is T50.2 a billable ICD-10 code?
Yes, T50.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T50.2?
Clinical documentation must specify the nature of Poisoning by, adverse effect of and underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics and any associated comorbidities for accurate reporting.
Cite this Clinical Reference